Activation of the cardiac α-myosin heavy chain (α-MHC) gene editing has emerged as a promising approach to induce positive inotropy...
Coffee and tea are two of the most popular beverages consumed worldwide. Not only do they provide a much-needed energy...
The Connection Between Substance Use Disorder and Higher Cardiac Mortality Rates Substance use disorder, commonly known as addiction, is a...
Exploring Perspectives on Mayo Clinic’s Phase 3 Publication on Stem Cells for Heart Disease In recent years, stem cell therapy...
Experienced Device Executive Jim Dillon Appointed as New CEO at BiVACOR, Reports Medical Device News Magazine In a recent announcement,...
CardioMech, a leading medical technology company, has recently announced the successful completion of a funding round, securing an impressive $13...
Boston Scientific, a leading medical device company, has recently reported the findings of the AVANT GUARD clinical trial on their...
Boston Scientific, a leading medical technology company, has recently reported the findings of its AVANT GUARD clinical trial on the...
Successful Pivotal Study Demonstrates Efficacy of Cytokinetics’ Heart Drug Aficamten Cytokinetics, a biopharmaceutical company focused on developing innovative treatments for...
Cytokinetics, a biopharmaceutical company focused on the development of muscle activators and inhibitors, is rapidly approaching a crucial deadline in...
Reducing Alcohol Consumption Can Lower the Risk of ‘Holiday Heart’ – Drugs.com MedNews The holiday season is a time of...
Proteins Expert from Smidt Heart Institute Receives Two Prestigious Biomedicine Awards, Reports Medical Device News Magazine Los Angeles, CA –...
A Preview of Biotech Clinical Trials in the Upcoming Year Biotechnology has revolutionized the field of medicine, offering innovative solutions...
Increase in Cases of Potentially Fatal Diphtheria Detected in the UK Diphtheria, a potentially fatal bacterial infection, has seen a...
Sequana Medical, a Swiss medical device company, recently announced promising results from a non-randomized cohort in the US Phase 1/2a...
